Epigenetic regulation has been linked to cancer, and The Economist notes that epigenetic processes "are susceptible to chemical intervention in a way that genetic mutations are not" — they could be affected by drugs. The Economist points to two recent talks given at the American Association for Cancer Research meeting in Chicago that described inhibitors that affect epigenetic regulation, though neither is ready to come to market.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.